Ghent University, Department of Clinical Chemistry, Microbiology and Immunology, Doping Control Laboratory, Technologiepark 30 B, B-9052, Zwijnaarde, Belgium.
Ghent University, Department of Clinical Chemistry, Microbiology and Immunology, Doping Control Laboratory, Technologiepark 30 B, B-9052, Zwijnaarde, Belgium.
Anal Chim Acta. 2018 Dec 26;1042:52-59. doi: 10.1016/j.aca.2018.08.050. Epub 2018 Aug 28.
In anti-doping, a high number of classes of substances are prohibited and laboratories need to detect these at low urinary concentrations. Traditionally, testing is done using complimentary liquid chromatography mass spectrometry and gas chromatography mass spectrometry. High resolution mass spectrometric acquisition has some important advantages over triple quadrupole instruments (e.g., open screening due to full scan high resolution data acquisition with retrospectivity, compatibility with libraries and a straightforward and effortless addition and validation of new compounds in the future). Doping samples can be stored for 10 years and retrospective data analysis can be used to re-evaluate previously acquired data (e.g., searching for prohibited (designer) substances that were unknown at the initial moment of analysis). During the past decade, these advantages have led to the wide-scale transfer of liquid chromatography triple quadrupole mass spectrometry screening to liquid chromatography high resolution mass spectrometry screening for doping control purposes. Up to now, for gas chromatography a similar switch to high resolution screening has not yet occurred, because so far no method has been developed that combines sufficient sensitivity with wide-scale drug detection. In this work, the current gas chromatography triple quadrupole mass spectrometry screening method for human doping control purposes was successfully converted into an equivalent and complete gas chromatography high resolution acquisition screening method. This new screening method on a gas chromatography quadrupole time-of-flight mass spectrometer has been developed and validated. The method is compliant with the World Anti-Doping Agency requirements and allows the detection of 294 target compounds (and 14 internal standards), including diuretics, stimulants, narcotics, beta-2-agonists, beta-blockers, hormone modulators, anabolic agents and the quantification of 14 endogenous steroids in a single fast run (14.1 min).
在反兴奋剂领域,有大量类别的物质被禁止使用,实验室需要在低尿液浓度下检测这些物质。传统上,检测工作是使用互补液相色谱-质谱联用和气相色谱-质谱联用完成的。高分辨质谱采集技术相对于三重四极杆仪器具有一些重要的优势(例如,由于具有回溯性的全扫描高分辨率数据采集而实现开放性筛选,与库的兼容性以及在未来轻松地添加和验证新化合物的能力)。兴奋剂样本可以保存 10 年,并且可以进行回溯数据分析,以重新评估之前获得的数据(例如,搜索在分析初始时刻未知的禁用(设计)物质)。在过去的十年中,这些优势导致了液相色谱三重四极杆质谱筛选在兴奋剂控制目的方面广泛地向液相色谱高分辨质谱筛选转移。到目前为止,对于气相色谱,尚未发生类似的向高分辨筛选的转变,因为到目前为止,还没有开发出一种方法,该方法将足够的灵敏度与广泛的药物检测相结合。在这项工作中,成功地将目前用于人类兴奋剂控制目的的气相色谱三重四极杆质谱筛选方法转换为等效且完整的气相色谱高分辨采集筛选方法。在气相色谱四极杆飞行时间质谱仪上开发并验证了这种新的筛选方法。该方法符合世界反兴奋剂机构的要求,允许在单次快速运行(14.1 分钟)中检测 294 种目标化合物(和 14 种内标),包括利尿剂、兴奋剂、麻醉剂、β-2-激动剂、β-阻断剂、激素调节剂、合成代谢制剂和 14 种内源性类固醇的定量。